Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium
Journal article published in 2022 by
Rakan Nasreddine,
Jean Cyr Yombi,
Gilles Darcis,
Eric Florence 
,
Sabine D. Allard,
Marie‐Angélique-A. De Scheerder,
Sophie Henrard,
Rémy Demeester,
Peter Messiaen,
Nathalie Ausselet,
Matthias Loeckx,
Marc Delforge,
Stéphane De Wit
,
Sabine D. Allard,
Marie‐Angélique-A. De Scheerder,
Sophie Henrard,
Rémy Demeester,
Peter Messiaen,
Nathalie Ausselet,
Matthias Loeckx,
Marc Delforge,
Stéphane De Wit
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 